Cargando…
Soluble ST2 and Galectin-3: What We Know and Don’t Know Analytically
The proteins soluble ST2 (sST2) and galectin-3 are currently gaining mounting interest as candidate biomarkers in cardiac disease. Both, sST2 and galectin-3 have been included in the 2013 ACCF/AHA guideline for additive risk stratification of patients with acute and chronic heart failure. The aim of...
Autores principales: | Mueller, Thomas, Dieplinger, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009947/ https://www.ncbi.nlm.nih.gov/pubmed/27683536 |
Ejemplares similares
-
International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020) -
Commentary: When we don't know what we don't know
por: Paone, Gaetano
Publicado: (2020) -
Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021) -
From CERN to Entrepreneurship: we don't know what we don't know
por: Zucchelli, Piero
Publicado: (2017) -
Zika: what we know and don't know
por: Diop, Doudou, et al.
Publicado: (2016)